Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
134,65 € ↑0,30 (0,22%)
2026-06-03
AKTIENPREIS
SecurityDE:NB3 / Neurocrine Biosciences, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership611,264 shares
Latest Disclosed Value $ 80,527,920
Franklin Resources Inc reports 14.74% increase in ownership of NB3 / Neurocrine Biosciences, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 611,264 shares of Neurocrine Biosciences, Inc. (DE:NB3) valued at $68,308,752 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 532,759 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 14.74% during the quarter. The current value of the position is $82,306,698 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 611,264 78,505 14.74 80,528 6.57 0.0197
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 532,759 -102,206 -16.10 75,561 -15.23 0.0185
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 634,965 -68,556 -9.74 89,136 0.80 0.0222
2025-08-12 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 703,521 124,092 21.42 88,426 37.98 0.0234
2025-05-13 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 579,429 -29,506 -4.85 64,085 -22.90 0.0184
2025-02-12 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 608,935 -55,401 -8.34 83,120 7.45 0.0231
2024-11-27 2024-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 664,336 -144,114 -17.83 77,355 -30.50 0.0217
2024-11-12 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 664,336 -144,114 77,355 0.0037
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 808,450 14,625 1.84 111,299 1.66 0.0342
2024-05-13 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 793,825 21,515 2.79 109,484 7.59 0.0347
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 772,310 6,124 0.80 101,760 18.06 0.0476
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 766,186 37,936 5.21 86,196 25.52 0.0438
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 728,250 17,806 2.51 68,674 -4.50 0.0326
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 710,444 16,672 2.40 71,911 -13.22 0.0361
2023-02-10 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 693,772 -358,463 -34.07 82,864 -25.85 0.0431
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,052,235 -128,820 -10.91 111,757 -2.93 0.0609
2022-08-11 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,181,055 65,313 5.85 115,129 10.06 0.0571
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,115,742 151,921 15.76 104,601 27.43 0.0418
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 963,821 -203 -0.02 82,088 -11.22 0.0296
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 964,024 1,490 0.15 92,459 -1.30 0.0348
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 962,534 57,680 6.37 93,674 6.45 0.0358
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 904,854 9,984 1.12 87,997 2.59 0.0358
2021-02-10 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 894,870 -635,290 -41.52 85,773 -41.71 0.0363
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,530,160 77,878 5.36 147,140 -22.32 0.0712
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,452,282 -225,399 -13.44 189,407 30.44 0.0976
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,677,681 -305,818 -15.42 145,203 -31.90 0.0969
2020-03-11 2019-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 1,983,499 122,980 6.61 213,207 27.17 0.1120
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,983,499 122,980 213,207 26,930.9631
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,860,519 208,688 12.63 167,651 20.21 0.0910
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,651,831 -387,307 -18.99 139,464 -22.37 0.0742
2019-05-15 2019-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 2,039,138 14,200 0.70 179,648 24.24 0.0962
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,039,138 14,200 179,648
2019-02-12 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,024,938 184,415 10.02 144,601 -36.10 0.0873
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,840,523 15,137 0.83 226,292 26.19 0.1127
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,825,386 -531,200 -22.54 179,326 -8.24 0.0920
2018-05-10 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,356,586 -714,800 -23.27 195,432 -17.99 0.0991
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,071,386 -194,229 -5.95 238,309 19.08 0.1144
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,265,615 -113,000 -3.34 200,117 28.76 0.0981
2017-08-10 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,378,615 579,900 20.72 155,416 28.25 0.0775
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,798,715 389,000 16.14 121,184 29.95 0.0615
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,409,715 397,429 19.75 93,256 -8.48 0.0483
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,012,286 470,840 30.55 101,902 45.45 0.0533
2016-08-11 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,541,446 380,841 32.81 70,059 52.63 0.0377
2016-05-10 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,160,605 -39,695 -3.31 45,902 -32.40 0.0244
2016-04-27 2015-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 1,200,300 -40,400 -3.26 67,901 37.54 0.0344
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,200,300 67,901
2015-11-10 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,240,700 -113,700 -8.39 49,367 -23.68 0.0244
2015-08-12 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,354,400 0 0.00 64,686 20.27 0.0294
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,354,400 -571,600 -29.68 53,783 25.00 0.0244
2015-02-10 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,926,000 87,600 4.77 43,027 49.36 0.0195
2014-11-12 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,838,400 -365,800 -16.60 28,808 -11.93 0.0131
2014-08-12 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,204,200 0 0.00 32,710 -7.83 0.0144
2014-05-13 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,204,200 105,600 5.03 35,488 81.05 0.0168
2014-02-12 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,098,600 495,800 30.93 19,601 8.03 0.0096
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,602,800 154,400 10.66 18,144 -6.38 0.0097
2013-08-09 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,448,400 1,448,400 19,380 0.0111
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.